Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023
29 August 2023 - 1:00PM
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field
of cellular metabolism pioneering therapies for rare diseases,
today announced that the company is scheduled to present at the
Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday,
September 12, 2023, at 7:30 a.m. EST.
A live webcast of the presentation can be accessed under "Events
& Presentations" in the Investors section of the company's
website at www.agios.com. A replay of the webcast will be archived
on the company’s website for at least two weeks following the
presentation.
About AgiosAgios is the pioneering leader in PK
activation and is dedicated to developing and delivering
transformative therapies for patients living with rare diseases. In
the U.S., Agios markets a first-in-class pyruvate kinase (PK)
activator for adults with PK deficiency, the first
disease-modifying therapy for this rare, lifelong, debilitating
hemolytic anemia. Building on the company's leadership in the field
of cellular metabolism and rare hematologic diseases, Agios is
advancing a robust clinical pipeline of investigational medicines
with programs in alpha- and beta-thalassemia, sickle cell disease,
pediatric PK deficiency and MDS-associated anemia. In addition to
its clinical pipeline, Agios has TMPRSS6 siRNA as a potential
treatment for polycythemia vera, a PAH stabilizer in preclinical
development as a potential treatment for phenylketonuria (PKU), and
deep scientific expertise in classical hematology. For more
information, please visit the company’s website at
www.agios.com.
Contacts:
Investor ContactChris Taylor, VP, Investor
Relations and Corporate CommunicationsAgios
PharmaceuticalsIR@agios.com
Media Contact Dan Budwick1AB Media
dan@1abmedia.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024